CivicMemory

Timeline / FDA — Press Announcements

changed Source changed

A new raw object was archived. Both versions are preserved. 4 line(s) added, 4 line(s) removed.

Evidence

SourceFDA — Press Announcements
AgencyFDA
URLhttps://www.fda.gov/news-events/newsroom/press-announcements
Observed by Civic Memory, directly, on 2026-08-28T00:21:03+00:00
Content typetext/html; charset=UTF-8
Current object 939ce97bc3db2e71ac299dbf049d1eb5973ed943461af5b6c962a7d162db0c35 download raw metadata
Previous object 77b000057f4eb65c975c70a9e3d6db50be2ac5b3f928fd921a9b1ee2aee349e5 download raw metadata

What changed derived

This diff is not evidence. It was produced by civic-memory.diff_engine 1.1.0 at 2026-08-28T00:21:03+00:00 by normalizing the two archived objects above. The objects are authoritative; this reading of them can be regenerated or deleted without loss. 4 line(s) added, 4 line(s) removed.

--- previous
+++ current
@@ -146,6 +146,10 @@
 
 August 27, 2026
 
+ - FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
+
+August 27, 2026
+
  - FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle
 
 August 26, 2026
@@ -179,10 +183,6 @@
 August 6, 2026
 
  - FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
-
-August 5, 2026
-
- - FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
 
 Pagination